|
NU1025
|
NU1025
|
90417-38-2
|
|
VTP-27999
|
N-[2-[(R)-(3-氯苯基)[(3R)-1-[[[(2S)-2-(甲基氨基)-3-[(3R)-四氢-2H-吡喃-3-基]丙基]氨基]羰基]-3-哌啶基]甲氧基]乙基]氨基甲酸甲酯
|
942142-51-0
|
|
SGA360
|
SGA360
|
680611-86-3
|
|
GJ103
|
GJ103 游离
|
1459687-89-8
|
|
NRC-2694
|
936446-61-6
|
936446-61-6
|
|
NPD8733
|
化合物NPD8733
|
696655-62-6
|
|
Baloxavir
|
巴洛沙韦
|
1985605-59-1
|
|
Amcenestrant
|
SAR-439859
|
2114339-57-8
|
|
Fluzoparib
|
氟唑帕利
|
1358715-18-0
|
|
AGI-41998
|
化合物 AGI-41998
|
2377492-26-5
|
|
Povorcitinib
|
INCB54707
|
1637677-22-5
|
|
Nemorubicin
|
奈莫柔比星
|
108852-90-0
|
|
Deferitrin
|
地夫立群
|
239101-33-8
|
|
AMAS
|
马来酰亚胺基乙酸琥珀酰亚胺酯
|
55750-61-3
|
|
BI605906
|
化合物 T14567
|
960293-88-3
|
|
IND24
|
4-([1,1'-biphenyl]-4-yl)-N-(6-methylpyridin-2-yl)thiazol-2-amine
|
1426047-44-0
|
|
BDP5290
|
BDP5290
|
1817698-21-7
|
|
ARS-1630
|
ARS-1630
|
1698055-86-5
|
|
RG7834
|
RO 7020322
|
2072057-17-9
|
|
MC-Val-Ala-PAB-PNP
|
Mc-Val-Ala-PAB-PNP
|
1639939-40-4
|
|
CC-90001
|
CC90001
|
1403859-14-2
|
|
Rineterkib
|
ERK-IN-1 (COMPOUND B)
|
1715025-32-3
|
|
CL2 Linker
|
CL2 Linker
|
2270986-66-6
|
|
Nitroflurbiprofen
|
158836-71-6
|
158836-71-6
|
|
BGC201531
|
BGC-20-1531
|
1186532-61-5
|
|
C188-9
|
432001-19-9
|
432001-19-9
|
|
Lasalocid sodium
|
拉沙里菌素
|
25999-20-6
|
|
BRD0705
|
BRD0705
|
2056261-41-5
|
|
NCGC00262650
|
NCGC00262650
|
344359-25-7
|
|
Takeda103A
|
Takeda103A
|
865609-72-9
|
|
Soporidine
|
化合物SOPORIDINE
|
1060376-43-3
|
|
IMM-H007
|
化合物IMM-H007
|
1221412-23-2
|
|
AGI-43192
|
化合物AGI-43192
|
2377491-54-6
|
|
CUR61414
|
CUR 61414
|
334998-36-6
|
|
Eribulin mesylate
|
甲磺酸艾日布林
|
441045-17-6
|
|
AH-3960
|
化合物AH-3960
|
862907-48-0
|
|
JNJ-42165279
|
N-(4-氯-3-吡啶基)-4-[(2,2-二氟-1,3-苯并二恶茂-5-基)甲基]-1-哌嗪甲酰胺
|
1346528-50-4
|
|
HBX 19818
|
9-氯-5,6,7,8-四氢-N-[3-[甲基(苄基)氨基]丙基]-2-吖啶甲酰胺
|
1426944-49-1
|
|
LYS01
|
LYS05
|
1391426-22-4
|
|
Preq1 Dihydrochloride
|
Pre-queuosine1 dihydrochloride
|
86694-45-3
|
|
APS-2-79
|
2002381-25-9
|
2002381-25-9
|
|
GNE-140 racemate
|
GNE140 racemate
|
1802977-61-2
|
|
Valnivudine
|
Valnivudine
|
956483-03-7
|
|
Epiblastin A
|
Epiblastin A
|
16470-02-3
|
|
VAF347
|
2-PYRIMIDINAMINE, 4-(3-CHLOROPHENYL)-N-[4-(TRIFLUOROMETHYL)PHENYL]-
|
574759-62-9
|
|
BRM/BRG1 ATP Inhibitor-1
|
1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA
|
2270879-17-7
|
|
MTI-31
|
MTI-31
|
1567915-38-1
|
|
EBOV/MARV-IN-1
|
VUN65671
|
2479465-67-1
|
|
FLTX1
|
2,1,3-Benzoxadiazol-4-amine, N-[2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]ethyl]-N-methyl-7-nitro-
|
1481401-71-1
|
|
Simmiparib
|
SIMMIPARIB
|
1551355-46-4
|
|
SW155246
|
4-Chloro-N-(4-hydroxy-1-naphthalenyl)-3-nitro-benzenesulfonamide
|
420092-79-1
|
|
RH01687
|
RH01687
|
302901-13-9
|
|
PF-06446846 hydrochloride
|
PF-06446846
|
1632250-50-0
|
|
Befotertinib
|
BEFOTERTINIB
|
1835667-63-4
|
|
Taltobulin
|
N,BETA,BETA-三甲基-L-苯基丙氨酰基-N-[(1S,2E)-3-羧基-1-(1-甲基乙基)-2-丁烯基]-N,3-二甲基-L-缬氨酰胺
|
228266-40-8
|
|
DD1
|
化合物DD1
|
187585-11-1
|
|
SAR405 R enantiomer
|
SAR405 R enantiomer
|
1946010-79-2
|
|
GPR84 antagonist 8
|
GPR84 ANTAGONIST 8
|
1445846-30-9
|
|
Desketoraloxifene
|
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenyl]-
|
216570-81-9
|
|
Povorcitinib phosphate
|
POVORCITINIB磷酸盐
|
1637677-33-8
|
|
Dilmapimod
|
444606-18-2
|
444606-18-2
|
|
GSK864
|
1816331-66-4
|
1816331-66-4
|
|
ML349
|
APT-2抑制剂
|
890819-86-0
|
|
ML-226
|
ML-226
|
2055172-43-3
|
|
SEMBL
|
SEMBL
|
1443448-82-5
|
|
MLN-4760
|
MLN-4760
|
305335-31-3
|
|
squarunkinA
|
化合物SQUARUNKINA
|
2101958-02-3
|
|
MMAE-SMCC
|
MMAE-SMCC
|
2021179-11-1
|
|
(αR,8aS)-GSK1614343
|
化合物 T27451
|
1092476-84-0
|
|
Sunvozertinib
|
DZD 9008
|
2370013-12-8
|
|
Sovilnesib
|
Sovilnesib
|
2410796-79-9
|
|
PD158780
|
N4-(3-溴苯基)-N6-甲基-吡啶并[3,4-D]嘧啶-4,6-二胺
|
171179-06-9
|
|
RP-6685
|
化合物RP-6685
|
2832047-80-8
|
|
SC-57461A
|
N -甲基- N -[3 - [4 - (苯甲基)苯氧基]丙基Β-丙氨酸盐酸盐
|
423169-68-0
|
|
BRD6688
|
BRD6688
|
1404562-17-9
|
|
TY-51469
|
CBRCULCCRGSSLB-UHFFFAOYSA-N
|
603987-59-3
|
|
KLH45
|
KLH45
|
1632236-44-2
|
|
INH154
|
化合物INH154
|
1587705-63-2
|
|
NVS-ZP7-4
|
NVS-ZP7-4
|
2349367-89-9
|
|
PKC-iota inhibitor 1
|
2-氨基-5-(3-(哌嗪-1-基)苯基)-N-(吡啶-4-基)烟酰胺
|
2328094-11-5
|
|
GW280264X
|
((S)-5-((2R,3S)-3-(N-羟基甲酰胺基)-2-异丁基六氨基)-2-氧代-6-(噻唑-2-基氨基)己基)氨基甲酸苄酯
|
866924-39-2
|
|
Eciruciclib
|
化合物 ECIRUCICLIB
|
1868086-40-1
|
|
Upacicalcet
|
乌帕西卡塞
|
1333218-50-0
|
|
NVP-DKY709
|
NVP-DKY709
|
2291360-73-9
|
|
MT 63-78
|
5-{2',6'-dihydroxy-[1,1'-biphenyl]-4-yl}-1H-indole-3-carbonitrile
|
1179347-65-9
|
|
AkaLumine
|
AKA LUMINE
|
1176235-08-7
|
|
GSK 366
|
GSK366)
|
1953157-39-5
|
|
GZD856
|
GZD856
|
1257628-64-0
|
|
Emavusertib
|
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-
|
1801344-14-8
|
|
Linaprazan glurate
|
Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester
|
1228559-81-6
|
|
Oritinib
|
化合物ORITINIB
|
2035089-28-0
|
|
Baxdrostat
|
BAXDROSTAT
|
1428652-17-8
|
|
TLR7/8-IN-1
|
TLR7/8-IN-1
|
2205095-75-4
|
|
Ginsenoside C-K
|
20(S)-人参皂苷 C-K
|
39262-14-1
|
|
Ala-Ala-Asn-PAB
|
ALA-ALA-ASN-PAB
|
2149584-00-7
|
|
JCP174
|
7-Amino-4-chloro-3-propoxy-isochromen-1-one
|
126062-19-9
|
|
GSK963
|
GSK963(S构型)
|
2049868-46-2
|
|
GSK-2793660
|
2H-Pyran-4-carboxamide, 4-amino-N-[(1S,2E)-4-(2,3-dihydro-1H-indol-1-yl)-1-ethyl-4-oxo-2-buten-1-yl]tetrahydro-
|
1613458-70-0
|
|
MC-Gly-Gly-Phe-Gly
|
Mc-GGFG-OH
|
2413428-36-9
|
|
Salirasib
|
法尼基硫代水杨酸
|
162520-00-5
|